Jg. Roddick et al., Membrane disruption and enzyme inhibition by naturally-occurring and modified chacotriose-containing Solanum steroidal glycoalkaloids, PHYTOCHEM, 56(6), 2001, pp. 603-610
Naturally-occurring 3 beta -O-chacotriosides of solasodine (solamargine), o
f its 22S, 25S isomer tomatidenol (beta -solamarine), and of solanidine (ch
aconine), as well as ring E- and F-modified derivatives of solamargine were
prepared and assayed in order to assess the relevance of aglycone structur
al features to membrane-disruption and enzyme-inhibitory activities of the
related glycoalkaloids. A rings E-opened dihydro-derivative of solasodine (
the chacotrioside of dihydrosolasodine A) did not bind to cholesterol, stig
masterol or ergosterol in vitro, disrupt PC/cholesterol liposomes or mammal
ian erythrocytes, or inhibit acetylcholinesterase in vitro. It did not syne
rgise with the solatrioside of dihydrosolasodine A or solasonine (nor did s
olamargine with dihydrosolasodine A solatrioside) in haemolysis tests. The
ring F modified derivative, N-nitrososolamargine, did not inhibit acetylcho
linesterase in vitro, but lysed liposomes at greater than or equal to 150 m
uM and pH 7. Increasing the pH to 8 (but not 9) further enhanced disruption
. The combination of N-nitrososolamargine and solasonine did not cause any
disruption of liposomes. beta -Solamarine showed no anti-acetylcholinestera
se activity in vitro at up to 100 muM, but disrupted liposomes at 75 and 15
0 muM, although not to the extent caused by solamargine or chaconine. In co
mbination with both the (inactive) solatriosides, solasonine and solanine,
75 muM beta -solamarine produced synergistic effects, with liposome disrupt
ion greater than 150 muM beta -solamarine alone, beta -Solamarine, solamarg
ine and chaconine showed similar haemolytic activity. beta -Solamarine syne
rgised with the solatriosides solasonine and solanine in disrupting erythro
cytes. Preliminary structure-activity relationships were evaluated for the
active chacotriosides in an attempt to define the scope and limitations of
this model study. (C) 2001 Elsevier Science Ltd. All rights reserved.